St Erik Eye Hospital
- Address
- lock Available on a paid plan
St Erik Eye Hospital
St Erik Eye Hospital is a specialized ophthalmic research center conducting advanced clinical trials in ocular oncology. The institution focuses on developing innovative therapeutic approaches for rare and serious eye cancers, with particular emphasis on improving long-term outcomes for patients with vision-threatening malignancies.
- Uveal melanoma treatment and metastasis prevention
- Adjuvant melatonin therapy in ocular oncology
- Long-term survival outcomes in eye cancer patients
The hospital is currently investigating the potential of adjuvant melatonin therapy as a novel approach to reduce metastatic spread in uveal melanoma patients. Through rigorous Phase III randomized controlled trials, researchers are evaluating whether extended melatonin treatment can improve five-year metastasis-free survival, representing a potentially groundbreaking advancement in the management of this rare intraocular cancer.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1St Erik Eye Hospital1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in St Erik Eye Hospital
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| AMUM trial -Adjuvant Melatonin for Uveal Melanoma: A randomized open Phase III Study | St Erik Eye Hospital | Phase III | Recruiting | Oct 2022 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Melatonin | 1 | Unknown | 2022-10-03 | 2022-10-03 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.